Parenteral elsamitrucin formulations

Details Parenteral elsamitrucin formulations Parenteral elsamitrucin formulations

1993-08-12

1996-04-16

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 41, 536 172, 536 187, 536 185, A61K 3171

Patent

active

055082688

ABSTRACT:
Stable parenteral antitumor formulations contain elsamitrucin salt, a stabilizer and a buffer. The formations are optionally stored in sealed containers under air or nitrogen headspace.

REFERENCES:
patent: 4518589 (1985-05-01), Konish et al.
patent: 4572895 (1986-02-01), Konish et al.
patent: 4873261 (1989-10-01), Miyazaki et al.
patent: 4963356 (1990-10-01), Calenoff et al.
Investigational New Drugs, Schurig, et al., 7:175-8 (1989).
American Association of Pharmaceutical Scientists (AAPS) 5th Annual Mtg. Nov. 4-8, 1990.
"The Merck Index", 11th ed.; S. Budavari, editor; Merck and Co., Inc; 1989, p. 1358.

Affiliated with

Also associated with

Rating

Parenteral elsamitrucin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral elsamitrucin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral elsamitrucin formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-325208